21 November 2026
Daily Current Affairs — 21 November 2026
Two verified developments from 20 November: regulatory permission for RAPP-8 first approach to criticality and dedication of India’s indigenous H5N1 poultry vaccine. Four verified MCQs; no verified canonical production PYQ links.
Science and TechnologyDP Score 87/1001. AERB permits first approach to criticality for Rajasthan Atomic Power Project Unit 8
Read more Read less
What Happened?
On 20 November 2026, the Atomic Energy Regulatory Board (AERB) announced that it had granted permission on 19 November for the First Approach to Criticality (FAC) of Rajasthan Atomic Power Project Unit 8 (RAPP-8), after completing the required safety reviews. The permission followed assessments of reactor design, construction, commissioning tests and operational preparedness, together with regulatory inspections. RAPP-8 is an indigenously designed 700 MWe Pressurised Heavy Water Reactor (PHWR) at Rawatbhata in Chittorgarh district, Rajasthan. It is the fourth unit of this Indian 700 MWe PHWR series, following Kakrapar Units 3 and 4 in Gujarat and RAPP Unit 7 in Rajasthan.
Why It Matters
The announcement marks a defined regulatory milestone in nuclear-reactor commissioning, not the start of commercial power generation. A reactor must demonstrate safe performance through subsequent commissioning tests and obtain further required regulatory permissions. The development links indigenous reactor engineering, electricity infrastructure and independent safety oversight. For exam preparation, the distinction between permission for first criticality and commercial operation is more durable than the exact announcement date.
Key Exam Facts
- AERB granted FAC permission on 19 November 2026; announcement on 20 November.
- RAPP-8 is a 700 MWe indigenously designed Pressurised Heavy Water Reactor.
- Location: Rawatbhata, Chittorgarh district, Rajasthan.
- Other three 700 MWe PHWR-series units: Kakrapar 3 and 4 (Gujarat), RAPP-7 (Rajasthan).
- AERB approval for FAC does not itself establish that criticality was achieved or commercial generation commenced.
Static–Current Linkage
Criticality is the condition in which a sustained nuclear fission chain reaction is established. Permission to attempt criticality precedes confirmation that the reactor has reached it. PHWR stands for Pressurised Heavy Water Reactor; heavy water serves as a neutron moderator in this reactor type. MWe denotes electrical power capacity, distinct from thermal capacity. Nuclear commissioning is staged: safety review and regulatory permission, first criticality and testing, then further clearances before commercial operation. The location also connects nuclear-power geography with Rajasthan and Gujarat.
Exam Edge
CDS/NDA/AFCAT: distinguish PHWR, heavy-water moderation, criticality and MWe. CAPF AC: relate AERB oversight to nuclear safety governance and energy infrastructure. Do not treat FAC permission as evidence of electricity being supplied to the grid.
Future Question Angles
Possible questions: Which authority grants reactor safety permissions? Where is RAPP-8 located? What does first criticality mean? Why does permission for FAC differ from commercial operation?
Primary source: https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2339225&lang=1®=1 (PIB, 20 November 2026). Verified linked production PYQs: none ([]).
Source date: 2026-11-20
Press Information Bureau, Government of IndiaGeneral Science and AgricultureDP Score 86/1002. India dedicates its first indigenous H5N1 poultry vaccine to the nation
Read more Read less
What Happened?
On 20 November 2026, Union Agriculture Minister Shivraj Singh Chouhan dedicated India’s first indigenous chicken vaccine against H5N1 avian influenza to the nation at Bhopal. The vaccine was developed by the ICAR–National Institute of High Security Animal Diseases (NIHSAD), Bhopal. An earlier PIB technical note specifies an inactivated vaccine targeting highly pathogenic avian influenza H5N1 clade 2.3.2.1a. The 20 November announcement described an intended price of ₹1–2 per dose and announced a proposed ₹300-crore animal disease research laboratory in Bhopal. These announcements do not independently establish nationwide distribution, measured field effectiveness or elimination of bird-flu outbreaks.
Why It Matters
Highly pathogenic avian influenza can cause severe poultry losses, disrupt farmers’ incomes and trade, and raise zoonotic-disease concerns. Indigenous vaccine development can strengthen animal-health preparedness and domestic research capacity. However, a vaccine launch is only one part of disease control; biosafety, surveillance, appropriate veterinary guidance and outbreak-response measures remain essential. The development provides a practical example of the One Health connection among animals, humans and their shared environment.
Key Exam Facts
- Vaccine dedicated on 20 November 2026 in Bhopal.
- Developing institution: ICAR–National Institute of High Security Animal Diseases (NIHSAD), Bhopal.
- Target: H5N1 highly pathogenic avian influenza in chickens; the earlier technical announcement specifies clade 2.3.2.1a.
- The vaccine is described as inactivated in the 18 November technical release.
- Announced indicative price: ₹1–2 per dose; proposed new animal-disease laboratory: ₹300 crore.
- A dedication event does not prove national rollout or field efficacy.
Static–Current Linkage
Avian influenza is caused by influenza A viruses; H5N1 identifies a haemagglutinin (H5) and neuraminidase (N1) subtype. Zoonoses are infectious diseases transmissible between animals and humans. Inactivated vaccines use virus rendered noninfectious as antigenic material, unlike live attenuated vaccines. One Health integrates human, animal and environmental health, especially relevant to zoonotic surveillance. An H5N1 poultry vaccine is not a human influenza vaccine, and a specific viral clade should not be confused with all H5N1 lineages.
Exam Edge
CDS/NDA/AFCAT: revise viral versus bacterial diseases, vaccine types, zoonoses and ICAR. CAPF AC: connect animal-disease control with One Health, livelihoods, biosecurity and public-health administration. Avoid unsupported claims of vaccine efficacy or nationwide deployment.
Future Question Angles
Possible questions: What pathogen causes bird flu? Which institute developed the vaccine? What is an inactivated vaccine? Why does poultry disease prevention matter for One Health?
Primary source: https://www.pib.gov.in/PressReleasePage.aspx?PRID=2339191&lang=1®=20 (PIB, 20 November 2026). Verified linked production PYQs: none ([]).
Source date: 2026-11-20
Press Information Bureau, Government of IndiaTest today’s Current Affairs
Which regulator granted permission for the First Approach to Criticality of RAPP Unit 8 in November 2026?